IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,739,070 | -16.5% | 1,180,744 | -0.7% | 0.01% | -14.3% |
| Q2 2023 | $22,440,154 | +390.4% | 1,189,219 | -0.2% | 0.01% | +250.0% |
| Q1 2023 | $4,575,836 | +38271.8% | 1,191,797 | -50.4% | 0.00% | -50.0% |
| Q4 2022 | $11,925 | -99.9% | 2,404,056 | -5.4% | 0.00% | -20.0% |
| Q3 2022 | $12,145,000 | +67.5% | 2,540,851 | +57.7% | 0.01% | +66.7% |
| Q2 2022 | $7,249,000 | +4669.1% | 1,611,076 | +7752.4% | 0.00% | – |
| Q4 2021 | $152,000 | -78.3% | 20,517 | -83.4% | 0.00% | – |
| Q3 2021 | $699,000 | -80.0% | 123,226 | -76.7% | 0.00% | -100.0% |
| Q2 2021 | $3,492,000 | +49785.7% | 529,821 | +48065.5% | 0.00% | – |
| Q4 2014 | $7,000 | -41.7% | 1,100 | 0.0% | 0.00% | – |
| Q3 2014 | $12,000 | -7.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | -18.8% | 1,100 | 0.0% | 0.00% | – |
| Q1 2014 | $16,000 | -11.1% | 1,100 | -12.0% | 0.00% | – |
| Q4 2013 | $18,000 | -14.3% | 1,250 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | -19.2% | 1,250 | -19.4% | 0.00% | – |
| Q2 2013 | $26,000 | – | 1,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |